Tower Research Capital (TRC)’s Haoxi Health Technology Ltd HAO Stock Holding History

Tower Research Capital (TRC)’s Portfolio HAO Stock Details HAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$2.92K	–	6061
2024 Q3	$2.92K	Buy	+3	New	+$35.3K	﹤0.01%	4922

Other funds holding HAO

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DCM

DGS Capital Management Jersey City, New Jersey $609M AUM 44.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s HAO Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Haoxi Health Technology Ltd (HAO) in Q4 2024, closing a stake of 3 shares — an estimated $2.92K sold.

Tower Research Capital (TRC) first reported a position in HAO in Q3 2024 and held it in 1 quarter. The position peaked at $2.92K in Q3 2024. 6 funds tracked by Wall St. Rank hold HAO as of Q4 2024.

Tower Research Capital (TRC) reported no remaining Haoxi Health Technology Ltd position as of Q4 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 3 Haoxi Health Technology Ltd shares in Q4 2024, an estimated $2.92K.
Tower Research Capital (TRC) first reported a position in Haoxi Health Technology Ltd in Q3 2024 and held it in 1 quarter.
Tower Research Capital (TRC)'s Haoxi Health Technology Ltd position peaked at $2.92K in Q3 2024.
6 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.